The challenges of psychopharmacogenetics.
作者信息
Catalano M
机构信息
Istituto di Ricovero e Cura a Carattere Scientifico H San Raffaele, DSNP, Milan, Italy.
出版信息
Am J Hum Genet. 1999 Sep;65(3):606-10. doi: 10.1086/302559.
Abstract
摘要
相似文献
1
The challenges of psychopharmacogenetics.
Am J Hum Genet. 1999 Sep;65(3):606-10. doi: 10.1086/302559.
2
No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder.
Mol Psychiatry. 2000 Sep;5(5):465-6. doi: 10.1038/sj.mp.4000772.
3
Psychiatric pharmacogenomics in pediatric psychopharmacology.
Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):773-88. doi: 10.1016/j.chc.2012.07.001.
4
Pharmacogenetics. Promise and potential in child and adolescent psychiatry.
Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):23-42, viii.
5
Perspectives and practical applications in psychopharmacogenetics.
Prog Neuropsychopharmacol. 1979;3(1-3):155-63. doi: 10.1016/0364-7722(79)90081-x.
6
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.
Hum Mol Genet. 1999 Apr;8(4):621-4. doi: 10.1093/hmg/8.4.621.
7
The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood.
Dev Psychopathol. 2012 Feb;24(1):267-85. doi: 10.1017/S0954579411000824.
8
Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders.
Am J Med Genet. 2002 May 8;114(4):380-90. doi: 10.1002/ajmg.10358.
9
Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder.
Eur Neuropsychopharmacol. 2003 Mar;13(2):93-8. doi: 10.1016/s0924-977x(02)00129-3.
10
[Status of and perspectives on psychiatric genomic medicine].
Ugeskr Laeger. 2005 May 16;167(20):2191-3.
引用本文的文献
1
Pathophysiology of depression and mechanisms of treatment.
Dialogues Clin Neurosci. 2002 Mar;4(1):7-20. doi: 10.31887/DCNS.2002.4.1/bbondy.
2
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.
Neuropsychiatr Dis Treat. 2005 Mar;1(1):17-35. doi: 10.2147/nedt.1.1.17.52301.
3
Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
J Mol Med (Berl). 2004 Jan;82(1):21-30. doi: 10.1007/s00109-003-0496-x. Epub 2003 Nov 4.
4
Genetic animal models of anxiety.
Neurogenetics. 2003 Apr;4(3):109-35. doi: 10.1007/s10048-003-0143-2. Epub 2003 Mar 29.
5
Pharmacogenetics of bipolar disorder.
Curr Psychiatry Rep. 2002 Apr;4(2):117-23. doi: 10.1007/s11920-002-0044-3.
6
Quantitative trait loci for the monoamine-related traits heart rate and headless behavior in Drosophila melanogaster.
Genetics. 2001 Jan;157(1):283-94. doi: 10.1093/genetics/157.1.283.
7
Genetic studies of alcoholism and substance dependence.
Am J Hum Genet. 1999 Sep;65(3):599-605. doi: 10.1086/302561.
本文引用的文献
1
Monoamine oxidase in neuropsychiatry and behavior.
Am J Hum Genet. 1999 Sep;65(3):593-8. doi: 10.1086/302562.
2
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.
Hum Mol Genet. 1999 Apr;8(4):621-4. doi: 10.1093/hmg/8.4.621.
3
Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
Mol Psychiatry. 1998 Nov;3(6):508-11. doi: 10.1038/sj.mp.4000425.
4
Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees.
J Psychiatr Res. 1998 Sep-Oct;32(5):255-9. doi: 10.1016/S0022-3956(98)00004-1.
5
Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia.
Biol Psychiatry. 1998 Sep 15;44(6):483-7. doi: 10.1016/s0006-3223(98)00134-6.
6
Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.
Am J Psychiatry. 1998 Sep;155(9):1278-80. doi: 10.1176/ajp.155.9.1278.
7
Panic and phobic anxiety: defining phenotypes for genetic studies.
Am J Psychiatry. 1998 Sep;155(9):1152-62. doi: 10.1176/ajp.155.9.1152.
8
Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia.
Schizophr Res. 1998 Jul 27;32(2):101-6. doi: 10.1016/s0920-9964(98)00038-3.
9
Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.
Schizophr Res. 1998 Jul 27;32(2):93-9. doi: 10.1016/s0920-9964(98)00032-2.
10
Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.
Neuropsychopharmacology. 1998 Aug;19(2):123-32. doi: 10.1016/S0893-133X(98)00007-4.
Zotero 插件